|
WO2020240550A1
|
|
Cannabidiol for treating type 1 diabetes mellitus
|
|
WO2020188569A1
|
|
Methods and compositions for preventing or treating weight gain caused by psychiatric drugs
|
|
WO2020183457A1
|
|
Cannabinoid combinations for treating diabetic neuropathy
|
|
WO2020183455A1
|
|
Cannabinoid combinations for treating low back pain
|
|
WO2020183456A1
|
|
Cannabinoid combinations for treating chronic pain in dialysis patients
|
|
WO2020021544A1
|
|
Cannabidiol and methylthio-butyl-isothiocyanate for treating inflammatory diseases
|
|
WO2020021545A1
|
|
Cannabidiol and glucosamine for treating inflammatory joint diseases
|
|
WO2020021543A1
|
|
Cannabidiol and curcumin for treating inflammatory diseases
|
|
WO2020188551A1
|
|
Methods and compositions for treating autism spectrum disorder and associated disorders
|
|
WO2019180706A1
|
|
Methods and compositions for treating epilepsy and associated disorders
|
|
WO2017203529A1
|
|
Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
|
|
US2020121616A1
|
|
Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
|
